L-NMMA . monoacetate
Endothelium-derived relaxing factor inhibitor. Inhibits the generation of NO from arginine. Competitive, irreversible non-selective inhibitor of all three NOS I, II, and III isoforms (eNOS, iNOS and nNOS). Inhibits the synthesis of nitric oxide (NO) in a dose-dependent and enantiospecific fashion. Useful tool to study the role and the effects of NO in cardiovascular and gastrointestinal disorders, hypertension, diabetes, septic shock, inflammation, infection, stroke and neurodegenerative disorders.
| Catalog Number | AG-CR1-3578-M100 |
| Alternative Name(s) | NG-Monomethyl-L-arginine . monoacetate |
| Research Area | Biochemicals, Immunology, Inflammation |
| Molecular Formula | C7H16N4O2 . CH3COOH |
| CAS# | 53308-83-1 |
| Purity | >99% |
| Inchi | InChI=1/C7H16N4O2.C2H4O2/c1-10-7(9)11-4-2-3-5(8)6(12)13;1-2(3)4/h5H,2-4,8H2,1H3,(H,12,13)(H3,9,10,11);1H3,(H,3,4)/t5-;/m0./s1 |
| Inchi Key | IKPNWIGTWUZCKM-JEDNCBNOBD |
| SMILES | CC([O-])=O.CNC(=N)NCCC[C@H]([NH3+])C(O)=O |
| Size | 100 mg |
| Supplier Page | http://www.adipogen.com/ag-cr1-3578/l-nmma-monoacetate.html |